Platelets and Platelet-Derived Microparticles in Vascular Inflammatory Disease

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 5, 2010-12 ,pp. : 346-354

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-activated Receptor-γ(PPARγ) Agonist Improves Coronary Artery Endothelial Function in Diabetic Patients with Coronary Artery Disease

By Yu J   Zhang Z   Li Z   Feng X   He L   Liu S   Mao J   Wang G   Wang X  

The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. : 86-94

Field House Publishing

Access to resources Recommend Favorite

Improvement in Endothelial Progenitor Cells from Peripheral Blood by Ramipril Therapy in Patients with Stable Coronary Artery Disease

By Min Tao Qian   Zhu Chen Jun   Xiang Wang Xing   Hui Zhu Jun   Peng Shang Yun  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 3, 2004-05 ,pp. : 203-209

Springer Publishing Company

Access to resources Recommend Favorite

Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery disease

By Böhm Felix   Jensen Jens   Svane Bertil   Settergren Magnus   Pernow John  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 11, 2008-11 ,pp. : 745-751

NRC Research Press

Access to resources Recommend Favorite

A polymorphism in the cytochrome P450 3A4 (CYP3A4) gene influences platelet activation and response to clopidogrel in patients with coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite